Differential regulation and properties of angiopoietin-like proteins 3 and 4
about
Atypical angiopoietin-like protein that regulates ANGPTL3Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fatAngiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertasesThe angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanismsLipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout miceMice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasisIdentification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolismAngiopoietin-Like Proteins: A Comprehensive LookIndirect genomic effects on survival from gene expression dataThe peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activityLack of relationship between cord serum angiopoietin-like protein 4 (ANGPTL4) and lipolytic activity in human neonates born by spontaneous delivery.A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro.High Concentrations of Angiopoietin-Like Protein 4 Detected in Serum from Patients with Rheumatoid Arthritis Can Be Explained by Non-Specific Antibody ReactivityInteraction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemiaANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.Angiopoietins and angiopoietin-like proteins in angiogenesis.Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.mRNA Expression of Ovine Angiopoietin-like Protein 4 Gene in Adipose TissuesEnterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3.Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production.Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and diseaseFasting and Feeding Signals Control the Oscillatory Expression of Angptl8 to Modulate Lipid Metabolism.Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway.Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome.Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting.Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin α(V)β₃/FAK/PI3K pathway-mediated Rac1 activation.Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipaseGenetic variation in ANGPTL4 provides insights into protein processing and function.ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
P2860
Q24303810-65AE8B78-D992-42C9-BA02-C7575642F759Q27324052-9CBB7AD0-E4ED-4BDB-9B3A-605810AB6BF6Q28116134-E5CBEE63-A66B-4615-B437-211F84D3179AQ28118447-24205ACC-4F1A-460F-A969-4FB212D0CDF0Q28235182-2B15F42F-9DD6-4286-BF07-A4DCA828DEFDQ28504875-937BE0BF-4DB1-4464-92C4-0D65C649D76BQ28508189-8B8A1B9A-5A3E-4FE4-9E41-431EE77D97DCQ29395294-787FAEDB-8829-4247-A7A7-A7A78492BC3BQ31150308-B8C296EC-6DE8-4DD8-9A0E-D2026E51F0A0Q33806178-16F009EF-550B-42CB-A336-5A6AF67AF40CQ34490931-79C809A5-E31D-4F37-A3C5-36DFF1FD0231Q34505898-E715991F-FDBA-410A-961A-E60BC585D946Q35040568-4468E9BC-3FCE-4101-9C38-6C0C838D368AQ35063919-4BE4B787-C461-45AB-A04A-ECCF2A7EF831Q35247596-4AB0D8D5-7EE5-48AC-8C18-DD9BB74D7CCCQ36255319-2E1D3DF9-0F44-49EA-909F-A305F8B540DFQ36302771-6DEA300E-155C-4F7B-8658-787CC83C5BFCQ36356225-423B4DBD-EE7B-47CA-8E7C-5857DCA8AC1AQ36489760-395093EB-A813-42A4-BEF1-07A1DF8986F4Q36515591-75577586-CA5B-4541-AFDA-BEC8465CFAE4Q36855095-1D88C184-D631-4A3A-AD5E-3FADC553C70FQ36882991-BE4D0225-AD2F-4456-A452-B386BD02E76FQ36930209-71887F41-BD79-495C-B256-CE2CB838C406Q36936141-5EFA7727-77A9-4194-9268-746AF1FF08E1Q36976999-98D41D25-7DEF-4992-BD5E-DD6990DCE884Q37036119-85739568-C5FA-4234-9F9C-F6560E8D3E2DQ37212217-A1AA0CBF-623D-4390-812C-6197BA8DF158Q37414206-B15F0EA7-6407-4604-9A2F-627C59CF4FE9Q37464651-BC4E2512-64B0-4AE3-8D6E-AAD861710F7BQ37611286-C8B4C41E-9BF9-4322-8A70-F509BBD9FB16Q38222802-96115368-4F7D-4E92-B347-89E05140C7AFQ38343977-DEE89233-BBE7-4116-9EF4-39D9FBF6A8E5Q40431221-F9576E30-8CBF-4058-838C-FD8B40FECE9DQ41069344-EDACBD83-A103-49B4-9581-44BC4E138A6EQ41865483-6853DE66-80DC-4D02-BD42-FE230DFCD263Q42065841-A5F1F8BF-FEA0-4C63-AF7B-416CA3683204Q42178295-0A3DD2CA-6829-4A32-B8EF-DFDB09A317A5Q42184230-8DF1AEE9-2570-479D-BFB9-96814F376D02Q42193259-BC088273-7646-471D-9239-30AC3EEBFE98Q42377853-501FF547-1554-4750-9498-737B4FC5C8D6
P2860
Differential regulation and properties of angiopoietin-like proteins 3 and 4
description
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juli 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/07/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/07/01)
@nl
наукова стаття, опублікована в липні 2005
@uk
مقالة علمية (نشرت في يوليو 2005)
@ar
name
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@ast
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@en
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@nl
type
label
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@ast
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@en
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@nl
prefLabel
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@ast
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@en
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@nl
P2093
P2860
P3181
P1476
Differential regulation and properties of angiopoietin-like proteins 3 and 4
@en
P2093
Christopher Harp
Harini Gopal
Hongfei Ge
Ji-Young Cha
Joyce J. Repa
P2860
P304
P3181
P356
10.1194/JLR.M500005-JLR200
P577
2005-07-01T00:00:00Z